Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC)

by A. Necchi, P. Grivas, G. Bratslavsky, O. Shapiro, J. Jacob, E. Sokol, J. Vergilio, J. Killian, D. Lin, J. Haberberger, J. Tse, S. Ramkissoon, E. Severson, A. Hemmerich, R. Huang, S. Ali, J. Chung, R. Madison, B. Alexander, P. Reddy, J. Elvin, A. Schrock, N. Danziger, J. Ross
Published 2020-07-01